ASHTON DEAR-HUFFMAN: Open Payments
NPI 1174284798 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,558 in 114 payments from 19 companies in 2025. Trend: 2023 $2,607 · 2024 $4,935 · 2025 $6,558
Food & beverage: $2,823Consulting: $2,250Travel & lodging: $1,400Education: $85
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 14 | $3,998 |
| ABBVIE INC. | 25 | $530 |
| Ardelyx, Inc. | 11 | $347 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $342 |
| Janssen Biotech, Inc. | 8 | $339 |
| QOL Medical, LLC | 10 | $257 |
| Ipsen Biopharmaceuticals, Inc | 4 | $198 |
| Celltrion USA Inc. | 4 | $88 |
| Gilead Sciences, Inc. | 4 | $81 |
| Regeneron Healthcare Solutions, Inc. | 3 | $75 |
Products named: TRULANCE, IBSRELA, TREMFYA, ENTYVIO, SKYRIZI, Sucraid, IQIRVO, RINVOQ.
Industry payments across VA — which companies pay providers there.
